These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2422800)
41. High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation. Nilsson T; Lenhoff S; Rylander L; Höglund M; Turesson I; Mitelman F; Westin J; Johansson B Br J Haematol; 2004 Aug; 126(4):487-94. PubMed ID: 15287940 [TBL] [Abstract][Full Text] [Related]
42. In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures. Stewart AK; Prince HM; Cappe D; Chu P; Lutzko C; Sutherland DR; Dubé ID Cancer Gene Ther; 1997; 4(3):148-56. PubMed ID: 9171933 [TBL] [Abstract][Full Text] [Related]
43. A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique. Orfäo A; García-Sanz R; López-Berges MC; Belén Vidriales M; González M; Caballero MD; San Miguel JF Cytometry; 1994 Dec; 17(4):332-9. PubMed ID: 7533074 [TBL] [Abstract][Full Text] [Related]
44. Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study. Fonseca R; Harrington D; Oken MM; Dewald GW; Bailey RJ; Van Wier SA; Henderson KJ; Blood EA; Rajkumar SV; Kay NE; Van Ness B; Greipp PR Cancer Res; 2002 Feb; 62(3):715-20. PubMed ID: 11830525 [TBL] [Abstract][Full Text] [Related]
45. G-banding analysis of complex aneuploidy in multiple myeloma bone marrow cells. Philip P; Drivsholm A Blood; 1976 Jan; 47(1):69-77. PubMed ID: 1244914 [TBL] [Abstract][Full Text] [Related]
46. Cytogenetic studies in patients with multiple myeloma. Kowalczyk JR; Dmoszyńska A; Chobotow M; Sokolowska B Cancer Genet Cytogenet; 1991 Sep; 55(2):173-9. PubMed ID: 1933820 [TBL] [Abstract][Full Text] [Related]
47. Temporal variation in nucleolar organizer region expression in bone marrow cells of individuals with leukemia. Kessler LG; Little BB; Redrow MW; Schneider NR Cancer Genet Cytogenet; 1988 Oct; 35(1):109-17. PubMed ID: 2460214 [TBL] [Abstract][Full Text] [Related]
48. Ag-NOR staining in human chromosomes: differential staining in normal and leukemic bone-marrow samples. Arden KC; Pathak S; Frankel LS; Zander A Int J Cancer; 1985 Dec; 36(6):647-9. PubMed ID: 2415466 [TBL] [Abstract][Full Text] [Related]
51. Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma. Depil S; Leleu X; Micol JB; Berthon C; Laï JL; Bauters F; Quesnel B; Facon T Leuk Lymphoma; 2004 Dec; 45(12):2481-4. PubMed ID: 15621764 [TBL] [Abstract][Full Text] [Related]
52. Differential nucleolus organizer activity in normal and leukemic bone marrow. Arden KC; Johnston DA; Cork A; Pathak S Am J Hematol; 1989 Mar; 30(3):164-73. PubMed ID: 2464925 [TBL] [Abstract][Full Text] [Related]
53. Risk groups of myeloma patients by histologic pattern and proliferative activity. Pich A; Chiusa L; Marmont F; Navone R Am J Surg Pathol; 1997 Mar; 21(3):339-47. PubMed ID: 9060605 [TBL] [Abstract][Full Text] [Related]
54. Two cases of t(9;20) in multiple myeloma. Jarosová M; Scudla V; Bacovský ; Indrák K; Sousková I; Bĕhal K Cancer Genet Cytogenet; 1996 Sep; 90(2):106-8. PubMed ID: 8830717 [TBL] [Abstract][Full Text] [Related]
55. Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parameters. Cigudosa JC; Calasanz MJ; Odero MD; Prosper F; Etxaniz A; Marin J; Rifón J; Gullón A; Rocha E Cancer Genet Cytogenet; 1994 Dec; 78(2):210-3. PubMed ID: 7828155 [TBL] [Abstract][Full Text] [Related]
56. Chromosomal abnormalities in multiple myeloma. Das KC; Aikat BK Blood; 1967 Dec; 30(6):738-48. PubMed ID: 6077426 [No Abstract] [Full Text] [Related]
57. [A case of no-anomaly type multiple myeloma with marked chromosomal abnormalities]. Nakayama S; Hattori Y; Itani S; Hoshino T Nihon Ketsueki Gakkai Zasshi; 1973 Apr; 36(2):139-49. PubMed ID: 4738465 [No Abstract] [Full Text] [Related]
58. [Chromosome studies in paraproteinemia]. Kanzow U; Lange B; Niederalt G; Gropp A Klin Wochenschr; 1967 Nov; 45(21):1076-84. PubMed ID: 4970245 [No Abstract] [Full Text] [Related]
59. Burkitt translocation (8;22)(q24;q11) in a patient with multiple myeloma. Look RM; Lim SW; Schreck RR; Lee S; Fuerst MP; Lawrence GN; Kusuanco DA; Kessler CE; Giles FJ Cancer Genet Cytogenet; 1995 Jul; 82(2):100-2. PubMed ID: 7664237 [TBL] [Abstract][Full Text] [Related]
60. Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities. Kriegova E; Fillerova R; Minarik J; Savara J; Manakova J; Petrackova A; Dihel M; Balcarkova J; Krhovska P; Pika T; Gajdos P; Behalek M; Vasinek M; Papajik T Sci Rep; 2021 Jul; 11(1):14671. PubMed ID: 34282158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]